Search
for
Sort by
Research 30 of 1000+
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Scarring Alopecia in Tumor Necrosis Factor-α Antagonists-Induced Scalp Psoriasis
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Hair-cycle changes in two patients taking tocilizumab
- SnapshotDx Quiz: September 2016
- Adverse Effects and Drug Interactions of Biologic Agents
- Clinical Snippets
- 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
- Novel therapies for alopecia areata: The era of rational drug development
- [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- 14. Wound Healing; Cutaneous Therapy; Hair
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Androgen receptor–mediated inhibition of cutaneous wound healing
- New treatments for rheumatoid arthritis
- Molecular cytokine-dependent mechanisms of periodontitis pathogenesis and the potential for pharmacological IL-1 modulation in disease treatment
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- The promotion of hair regrowth by topical application of a Perilla frutescens extract through increased cell viability and antagonism of testosterone and dihydrotestosterone
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review